Alliance A042302

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
Protocol A042302, Phase III Evaluation of Fixed Duration Zanubrutinib plus Sonrotoclax-Based Therapy Compared to Continuous Zanubrutinib in Previously Untreated Older Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Principal Investigator
Headshot of Danielle Marie Brander
Associate Professor of Medicine
Protocol Number
IRB: PRO00120149
NCT: NCT07321652
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL
Participate